Leonteq Securities’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Leonteq Securities's MRNA Position: Q3 2026 in Review
Leonteq Securities reduced its Moderna (MRNA) stake by 43% in Q3 2026, selling an estimated $12.4M and leaving 152,218 shares worth $29.3M. The position accounts for 1.2% of the portfolio, ranked #18.
Leonteq Securities first reported a position in MRNA in Q4 2020 and has held it in 24 quarters since. The position peaked at $43.1M in Q2 2022. 858 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- Leonteq Securities held 152,218 shares of Moderna worth $29.3M as of Q3 2026.
- Leonteq Securities sold 114,913 Moderna shares in Q3 2026, an estimated $12.4M.
- Moderna made up 1.2% of Leonteq Securities's portfolio in Q3 2026, its #18 holding.
- Leonteq Securities first reported a position in Moderna in Q4 2020 and has held it in 24 quarters since.
- Leonteq Securities's Moderna position peaked at $43.1M in Q2 2022.
- 858 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.